Cortisone Treatment for the Prevention of Postoperative Pancreatitis and Pancreatitis-induced Complications After Pancreaticoduodenectomy and Distal Pancreatic Resection

Tampere University Hospital

Status and phase: Completed; Phase 2

Conditions: Postoperative Complications; Postoperative Pancreatitis

Treatments: Drug: Hydrocortisone

Study type: Interventional

Funder types: Other

Identifiers

NCT01460615

R11009M

Details and patient eligibility

About

The purpose of this randomized, placebo-controlled trial is to investigate whether postoperative pancreatitis and other immediate complications after pancreaticoduodenectomy or distal pancreatic resection may be reduced with cortisone treatment. Treatment is administered to high risk patients (defined by high amount of acinar cells in the cut edge of pancreas).

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pancreaticoduodenectomy and distal pancreatectomy patients in Tampere University Hospital

Exclusion criteria

• Patients with an ongoing cortisone treatment
• Cefuroxime allergy
• Chronic pancreatitis